Acute haematogenous prosthetic joint infection: Prospective evaluation of medical and surgical management

D. Rodríguez, C. Pigrau, G. Euba, J. Cobo, J. García-Lechuz, J. Palomino, M. Riera, M. D. Del Toro, A. Granados, X. Ariza

    Research output: Contribution to journalArticleResearchpeer-review

    59 Citations (Scopus)


    The optimum treatment for prosthetic joint infections has not been clearly defined. We report our experience of the management of acute haematogenous prosthetic joint infection (AHPJI) in patients during a 3-year prospective study in nine Spanish hospitals. Fifty patients, of whom 30 (60%) were female, with a median age of 76 years, were diagnosed with AHPJI. The median infection-free period following joint replacement was 4.9 years. Symptoms were acute in all cases. A distant previous infection and/or bacteraemia were identified in 48%. The aetiology was as follows: Staphylococcus aureus, 19; Streptococcus spp., 14; Gram-negative bacilli, 12; anaerobes, two; and mixed infections, three. Thirty-four (68%) patients were treated with a conservative surgical approach (CSA) with implant retention, and 16 had prosthesis removal. At 2-year follow-up, 24 (48%) were cured, seven (14%) had relapsed, seven (14%) had died, five (10%) had persistent infection, five had re-infection, and two had an unknown evolution. Overall, the treatment failure rates were 57.8% in staphylococcal infections and 14.3% in streptococcal infections. There were no failures in patients with Gram-negative bacillary. By multivariate analysis, CSA was the only factor independently associated with treatment failure (OR 11.6; 95% CI 1.29-104.8). We were unable to identify any factors predicting treatment failure in CSA patients, although a Gram-negative bacillary aetiology was a protective factor. These data suggest that although conservative surgery was the only factor independently associated with treatment failure, it could be the first therapeutic choice for the management of Gram-negative bacillary and streptococcal AHPJI, and for some cases with acute S. aureus infections. © 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.
    Original languageEnglish
    Pages (from-to)1789-1795
    JournalClinical Microbiology and Infection
    Issue number12
    Publication statusPublished - 1 Jan 2010


    • Acute infection
    • Antibiotic therapy
    • Haematogenous infection
    • Prosthetic joint infections
    • Treatment


    Dive into the research topics of 'Acute haematogenous prosthetic joint infection: Prospective evaluation of medical and surgical management'. Together they form a unique fingerprint.

    Cite this